 |
 Video: Compound Annual Growth Rate (CAGR) Definition
|
|
| Date |
Open |
High |
Low |
Close |
Volume |
| 04/01/2024 |
$1.56 |
$1.58 |
$1.55 |
$1.56 |
1.33M | | 04/02/2024 |
$1.56 |
$1.57 |
$1.55 |
$1.56 |
869.60K | | 04/03/2024 |
$1.56 |
$1.57 |
$1.55 |
$1.56 |
771.10K | | 04/04/2024 |
$1.56 |
$1.57 |
$1.54 |
$1.54 |
2.39M | | 04/05/2024 |
$1.54 |
$1.54 |
$1.54 |
$1.54 |
0 |
|
|
| NGM Biopharmaceuticals is a biopharmaceutical company. Co. has five product candidates in the clinic, three wholly-owned by Co. (NGM707, NGM120 and aldafermin), one being progressed by its collaborator, Merck Sharp & Dohme Corp., or Merck (MK-3655) and one optionable by Merck (NGM621). Co.'s oncology product candidates include NGM707, NGM831, NGM438 and NGM120 and their related compounds. NGM621 was engineered to bind to, and be a long-acting inhibitor of, complement C3 with the treatment goal of reducing disease progression in patients with geographic atrophy, secondary to age-related macular degeneration. MK-3655 isin Phase 2b development for the treatment of nonalcoholic steatohepatitis. | |
|
Ngm Biopharmaceuticals (NGM) has the following price history information. Looking back at NGM historical stock prices for the last five trading days, on April 01, 2024, NGM opened at $1.56, traded as high as $1.58 and as low as $1.55, and closed at $1.56. Trading volume was a total of 1.33M shares. On April 02, 2024, NGM opened at $1.56, traded as high as $1.57 and as low as $1.55, and closed at $1.56. Trading volume was a total of 869.60K shares. On April 03, 2024, NGM opened at $1.56, traded as high as $1.57 and as low as $1.55, and closed at $1.56. Trading volume was a total of 771.10K shares. On April 04, 2024, NGM opened at $1.56, traded as high as $1.57 and as low as $1.54, and closed at $1.54. Trading volume was a total of 2.39M shares. On April 05, 2024, NGM opened at $1.54, traded as high as $1.54 and as low as $1.54, and closed at $1.54. Trading volume was a total of 0 shares.
NGM Historical Stock Prices By Date:
Below, we examine the compound annual growth rate — CAGR for short — of an investment into Ngm Biopharmaceuticals shares, starting with a $10,000 purchase of NGM, and working forward through the historical stock price information to today.
Growth of $10,000.00
Without Dividends Reinvested
|
| Start date: |
04/05/2019 |
|
| End date: |
04/05/2024 |
|
| Start price/share: |
$15.10 |
|
| End price/share: |
$1.54 |
|
| Dividends collected/share: |
$0.00 |
|
| Total return: |
-89.80% |
|
| Average Annual Total Return: |
-36.62% |
|
| Starting investment: |
$10,000.00 |
|
| Ending investment: |
$1,020.18 |
|
| Years: |
5.01 |
|
|
|
| Date |
Close |
| 04/01/2024 | $1.56 | | 04/02/2024 | $1.56 | | 04/03/2024 | $1.56 | | 04/04/2024 | $1.54 | | 04/05/2024 | $1.54 |
|
|
Free NGM Email Alerts:
